Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-8 ERVK-11	7.14e-07	11	139	4	GO:0004523
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-8 ERVK-11	2.13e-06	14	139	4	GO:0003964
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-8 ERVK-18 ERVK-25	5.54e-06	37	139	5	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-8 ERVK-18 ERVK-25	6.35e-06	38	139	5	GO:0070001
GeneOntologyMolecularFunction	catalytic activity, acting on RNA	ERVK-6 XRN2 DHX57 ERVK-7 LARS2 PARS2 CDKAL1 DUS2 TRMT10A ERVK-8 DDX23 ERVK-11 DDX11L8	7.18e-06	417	139	13	GO:0140098
GeneOntologyMolecularFunction	endopeptidase activity	ERVK-6 ADAM9 CASP1 CASP2 ERVK-7 ADAM12 MST1 HP ADAMTS16 ERVK-8 ERVK-18 C1R ERVK-25	9.97e-06	430	139	13	GO:0004175
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-8 ERVK-11	1.23e-05	21	139	4	GO:0035613
GeneOntologyMolecularFunction	peptidase activity	CYLD ERVK-6 USP45 ADAM9 CASP1 CASP2 ERVK-7 ADAM12 MST1 HP ADAMTS16 ERVK-8 ERVK-18 C1R ERVK-25	5.22e-05	654	139	15	GO:0008233
GeneOntologyMolecularFunction	heparin binding	SMOC2 TGFBR3 SLIT2 ANOS1 PTPRC SLIT1 CXCL6 CCN3	6.08e-05	192	139	8	GO:0008201
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-8 ERVK-11	1.24e-04	37	139	4	GO:0016891
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-6 ERVK-7 ERVK-8 ERVK-11	1.38e-04	38	139	4	GO:0034061
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	ERVK-6 XRN2 DHX57 ERVK-7 LARS2 PARS2 CDKAL1 CRY1 DUS2 TRMT10A ERVK-8 DDX23 ERVK-11 DDX11L8	1.67e-04	645	139	14	GO:0140640
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-8 ERVK-11	2.92e-04	46	139	4	GO:0016893
GeneOntologyMolecularFunction	sulfur compound binding	ACACB SMOC2 TGFBR3 SLIT2 ANOS1 PTPRC SLIT1 CXCL6 CCN3	4.42e-04	323	139	9	GO:1901681
GeneOntologyMolecularFunction	glycosaminoglycan binding	SMOC2 TGFBR3 SLIT2 ANOS1 PTPRC SLIT1 CXCL6 CCN3	5.88e-04	268	139	8	GO:0005539
GeneOntologyMolecularFunction	heparan sulfate proteoglycan binding	SLIT2 PTPRC SLIT1	1.06e-03	29	139	3	GO:0043395
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2D KMT2A	1.31e-03	8	139	2	GO:0140945
GeneOntologyMolecularFunction	coreceptor activity	TGFBR3 GPC4 LRP5 IL6ST	1.60e-03	72	139	4	GO:0015026
GeneOntologyMolecularFunction	laminin binding	GPC1 ADAM9 SLIT2	1.69e-03	34	139	3	GO:0043236
GeneOntologyMolecularFunction	extracellular matrix binding	GPC1 ADAM9 SMOC2 SLIT2	1.69e-03	73	139	4	GO:0050840
GeneOntologyMolecularFunction	PDZ domain binding	SRR CCDC88C TGFBR3 ATP2B4 MUSK	1.70e-03	123	139	5	GO:0030165
GeneOntologyBiologicalProcess	synapse assembly	NRCAM ADGRL1 MDGA2 CLSTN2 GRIN1 CRKL RHOA SLIT2 LRFN5 CNTN5 SLIT1 GPC4 MUSK	1.72e-07	308	139	13	GO:0007416
GeneOntologyBiologicalProcess	regulation of synapse assembly	ADGRL1 MDGA2 CLSTN2 GRIN1 RHOA SLIT2 LRFN5 SLIT1 GPC4 MUSK	1.16e-06	202	139	10	GO:0051963
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-7 ERVK-8 ERVK-11	1.35e-06	13	139	4	GO:0015074
GeneOntologyBiologicalProcess	cell junction assembly	NRCAM WHAMM ADGRL1 MDGA2 CLSTN2 GRIN1 CRKL RHOA RHOC SLIT2 LRFN5 CNTN5 TLN1 SLIT1 GPC4 MUSK	1.50e-06	569	139	16	GO:0034329
GeneOntologyBiologicalProcess	regulation of cell junction assembly	ADGRL1 MDGA2 CLSTN2 GRIN1 RHOA SLIT2 LRFN5 TLN1 SLIT1 GPC4 MUSK	8.14e-06	309	139	11	GO:1901888
GeneOntologyBiologicalProcess	regulation of synapse organization	NRCAM ADGRL1 MDGA2 CLSTN2 GRIN1 RHOA SLIT2 LRFN5 SLIT1 GPC4 ARC MUSK	1.26e-05	387	139	12	GO:0050807
GeneOntologyBiologicalProcess	regulation of synapse structure or activity	NRCAM ADGRL1 MDGA2 CLSTN2 GRIN1 RHOA SLIT2 LRFN5 SLIT1 GPC4 ARC MUSK	1.54e-05	395	139	12	GO:0050803
GeneOntologyBiologicalProcess	skeletal muscle satellite cell migration	RHOA RHOC	4.51e-05	2	139	2	GO:1902766
GeneOntologyBiologicalProcess	regulation of cellular component biogenesis	CYLD CCP110 WASHC2C ADGRL1 MDGA2 CLSTN2 GRIN1 SAXO1 RHOA RHOC TGFBR3 SLIT2 RHPN2 SLF2 LRFN5 TLN1 SLIT1 GPC4 ADAMTS16 CEP295 MUSK	4.72e-05	1189	139	21	GO:0044087
GeneOntologyBiologicalProcess	bone marrow development	ASXL1 PTPRC LRP5	4.75e-05	11	139	3	GO:0048539
GeneOntologyBiologicalProcess	synapse organization	NRCAM ADGRL1 MDGA2 CLSTN2 GRIN1 CRKL RHOA SLIT2 LRFN5 CNTN5 SLIT1 GPC4 ARC LRP5 MUSK	6.12e-05	685	139	15	GO:0050808
GeneOntologyBiologicalProcess	positive regulation of skeletal muscle acetylcholine-gated channel clustering	CRKL LRP5 MUSK	6.30e-05	12	139	3	GO:1904395
GeneOntologyBiologicalProcess	cell junction organization	NRCAM WHAMM ADGRL1 MDGA2 CLSTN2 GRIN1 CRKL RHOA RHOC SLIT2 LRFN5 CNTN5 TLN1 SLIT1 GPC4 ARC LRP5 MUSK	9.81e-05	974	139	18	GO:0034330
GeneOntologyBiologicalProcess	regulation of skeletal muscle acetylcholine-gated channel clustering	CRKL LRP5 MUSK	1.28e-04	15	139	3	GO:1904393
GeneOntologyBiologicalProcess	chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration	SLIT2 SLIT1	1.35e-04	3	139	2	GO:0021834
GeneOntologyBiologicalProcess	mammary gland duct morphogenesis	TFAP2C MST1 SLIT2 LRP5	2.37e-04	45	139	4	GO:0060603
GeneOntologyBiologicalProcess	regulation of cardiac muscle hypertrophy in response to stress	ACACB ERRFI1 ATP2B4	2.68e-04	19	139	3	GO:1903242
GeneOntologyBiologicalProcess	positive regulation of receptor clustering	CRKL LRP5 MUSK	2.68e-04	19	139	3	GO:1903911
GeneOntologyBiologicalProcess	dorsal/ventral axon guidance	SLIT2 SLIT1	2.68e-04	4	139	2	GO:0033563
GeneOntologyBiologicalProcess	cell-cell fusion	ERVK-6 ADAM9 CASP1 ADAM12 ERVK-8	2.75e-04	85	139	5	GO:0140253
GeneOntologyBiologicalProcess	syncytium formation by plasma membrane fusion	ERVK-6 ADAM9 CASP1 ADAM12 ERVK-8	2.75e-04	85	139	5	GO:0000768
GeneOntologyBiologicalProcess	DNA synthesis involved in DNA repair	ERVK-6 ERVK-7 ERVK-8 ERVK-11	3.05e-04	48	139	4	GO:0000731
GeneOntologyBiologicalProcess	regulation of cardiac muscle adaptation	ACACB ERRFI1 ATP2B4	3.14e-04	20	139	3	GO:0010612
GeneOntologyBiologicalProcess	cell-cell adhesion	CYLD NRCAM ADAM9 ADGRL1 MDGA2 CLSTN2 RHOA SLIT2 CD5 PTPRC LRFN5 CNTN5 TLN1 GPC4 LRP5 NFAT5 IL6ST CCN3	3.38e-04	1077	139	18	GO:0098609
GeneOntologyBiologicalProcess	syncytium formation	ERVK-6 ADAM9 CASP1 ADAM12 ERVK-8	3.41e-04	89	139	5	GO:0006949
GeneOntologyBiologicalProcess	skeletal muscle acetylcholine-gated channel clustering	CRKL LRP5 MUSK	3.64e-04	21	139	3	GO:0071340
GeneOntologyBiologicalProcess	telencephalon development	XRN2 GRIN1 TFAP2C CRKL RHOA SLIT2 SLIT1 HERC1 ATP2B4	4.27e-04	332	139	9	GO:0021537
GeneOntologyBiologicalProcess	embryonic olfactory bulb interneuron precursor migration	SLIT2 SLIT1	4.45e-04	5	139	2	GO:0021831
Domain	CTCK_1	SLIT2 SLIT1 CCN3	2.66e-04	18	133	3	PS01185
Domain	CT	SLIT2 SLIT1 CCN3	4.92e-04	22	133	3	SM00041
Domain	FYrich_C	KMT2D KMT2A	4.96e-04	5	133	2	IPR003889
Domain	FYrich_N	KMT2D KMT2A	4.96e-04	5	133	2	IPR003888
Domain	FYRC	KMT2D KMT2A	4.96e-04	5	133	2	SM00542
Domain	FYRN	KMT2D KMT2A	4.96e-04	5	133	2	SM00541
Domain	FYRN	KMT2D KMT2A	4.96e-04	5	133	2	PF05964
Domain	FYRC	KMT2D KMT2A	4.96e-04	5	133	2	PF05965
Domain	FYRC	KMT2D KMT2A	4.96e-04	5	133	2	PS51543
Domain	FYRN	KMT2D KMT2A	4.96e-04	5	133	2	PS51542
Domain	FN3	NRCAM MDGA2 ANOS1 PTPRC LRFN5 CNTN5 IL6ST	5.63e-04	199	133	7	PS50853
Domain	Cys_knot_C	SLIT2 SLIT1 CCN3	7.24e-04	25	133	3	IPR006207
Domain	CTCK_2	SLIT2 SLIT1 CCN3	7.24e-04	25	133	3	PS01225
Domain	GLYPICAN	GPC1 GPC4	7.41e-04	6	133	2	PS01207
Domain	Glypican	GPC1 GPC4	7.41e-04	6	133	2	IPR001863
Domain	Glypican_CS	GPC1 GPC4	7.41e-04	6	133	2	IPR019803
Domain	Glypican	GPC1 GPC4	7.41e-04	6	133	2	PF01153
Domain	FN3_dom	NRCAM MDGA2 ANOS1 PTPRC LRFN5 CNTN5 IL6ST	7.52e-04	209	133	7	IPR003961
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS	RHOA RHOC RHPN2	3.55e-05	9	108	3	M27551
Pathway	REACTOME_SEMAPHORIN_INTERACTIONS	RHOA RHOC PTPRC TLN1 PLXNA2	4.27e-05	51	108	5	MM14967
Pathway	REACTOME_SEMAPHORIN_INTERACTIONS	RHOA RHOC PTPRC TLN1 PLXNA2	1.28e-04	64	108	5	M7923
Pathway	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	GPC1 GRIN1 GFRA1 RHOA RHOC SLIT2 PTPRC TLN1 PLXNA2	1.76e-04	261	108	9	MM15676
Pathway	WP_SPINAL_CORD_INJURY	GRIN1 RHOA RHOC SLIT2 SLIT1 PLXNA2	1.79e-04	108	108	6	MM15954
Pubmed	Mammalian homologues of the Drosophila slit protein are ligands of the heparan sulfate proteoglycan glypican-1 in brain.	GPC1 SLIT2 SLIT1	6.52e-08	3	141	3	10364234
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CYLD ASXL1 WASHC2C NRCAM ADAM9 ADGRL1 PRRC2C TLN1 SLIT1 NFAT5 BAIAP3 PLXNA2	1.15e-07	407	141	12	12693553
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-18	6.48e-07	5	141	3	12629516
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-8 ERVK-18 ERVK-25 ERVK-11	2.42e-06	94	141	6	21542922
Pubmed	LRP4 serves as a coreceptor of agrin.	CRKL LRP5 MUSK	3.60e-06	8	141	3	18957220
Pubmed	The mutational landscape of lethal castration-resistant prostate cancer.	ASXL1 KMT2D KMT2A	3.60e-06	8	141	3	22722839
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	CYLD CCP110 NEDD1 CCDC15 MAP7D2 CEP295	3.69e-06	101	141	6	24613305
Pubmed	WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development.	KMT2D CBX1 KMT2A	5.38e-06	9	141	3	15960974
Pubmed	Neuronal Ig/Caspr recognition promotes the formation of axoaxonic synapses in mouse spinal cord.	NRCAM CASP1 CNTN5	1.40e-05	12	141	3	24411736
Pubmed	Patterning of the basal telencephalon and hypothalamus is essential for guidance of cortical projections.	SLIT2 NKX2-4 SLIT1	1.40e-05	12	141	3	11830575
Pubmed	RhoA GTPase is dispensable for actomyosin regulation but is essential for mitosis in primary mouse embryonic fibroblasts.	RHOA RHOC	1.63e-05	2	141	2	21454503
Pubmed	Activation of a bacterial virulence protein by the GTPase RhoA.	RHOA RHOC	1.63e-05	2	141	2	19887681
Pubmed	Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.	RHOA RHOC	1.63e-05	2	141	2	12808121
Pubmed	RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation.	RHOA RHPN2	1.63e-05	2	141	2	23774217
Pubmed	Clinical and next-generation sequencing findings in a Chinese family exhibiting severe familial exudative vitreoretinopathy.	ABCA4 LRP5	1.63e-05	2	141	2	29207047
Pubmed	Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo.	KMT2D KMT2A	1.63e-05	2	141	2	26711341
Pubmed	Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.	RHOA RHOC	1.63e-05	2	141	2	20503409
Pubmed	Guanine nucleotide exchange regulates membrane translocation of Rac/Rho GTP-binding proteins.	RHOA RHOC	1.63e-05	2	141	2	7989340
Pubmed	Nanobody-Based Quantification of GTP-Bound RHO Conformation Reveals RHOA and RHOC Activation Independent from Their Total Expression in Breast Cancer.	RHOA RHOC	1.63e-05	2	141	2	33825439
Pubmed	Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo.	RHOA RHOC	1.63e-05	2	141	2	20828398
Pubmed	Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.	KMT2D KMT2A	1.63e-05	2	141	2	24423662
Pubmed	Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.	RHOA RHOC	1.63e-05	2	141	2	15668138
Pubmed	Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.	RHOA RHOC	1.63e-05	2	141	2	17896152
Pubmed	Sequence of rho small GTP-binding protein cDNAs from human retina and identification of novel 5' end cloning artifacts.	RHOA RHOC	1.63e-05	2	141	2	7835413
Pubmed	Permissive corridor and diffusible gradients direct medial ganglionic eminence cell migration to the neocortex.	SLIT2 SLIT1	1.63e-05	2	141	2	12515855
Pubmed	Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes.	SLIT2 SLIT1	1.63e-05	2	141	2	12200164
Pubmed	Directional guidance of neuronal migration in the olfactory system by the protein Slit.	SLIT2 SLIT1	1.63e-05	2	141	2	10432110
Pubmed	ABCs of RhoGTPases indicating potential role as oncotargets.	RHOA RHOC	1.63e-05	2	141	2	28508825
Pubmed	Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters.	RHOA RHOC	1.63e-05	2	141	2	19499974
Pubmed	Characterization of Slit protein interactions with glypican-1.	GPC1 SLIT2	1.63e-05	2	141	2	11375980
Pubmed	Steerable-filter based quantification of axonal populations at the developing optic chiasm reveal significant defects in Slit2(-/-) as well as Slit1(-/-)Slit2(-/-) embryos.	SLIT2 SLIT1	1.63e-05	2	141	2	23320558
Pubmed	Slit1 and slit2 proteins control the development of the lateral olfactory tract.	SLIT2 SLIT1	1.63e-05	2	141	2	12097499
Pubmed	Protease Activity Profiling via Programmable Phage Display of Comprehensive Proteome-Scale Peptide Libraries.	CASP1 HUWE1	1.63e-05	2	141	2	33099407
Pubmed	Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior.	RHOA RHOC	1.63e-05	2	141	2	21208644
Pubmed	Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.	RHOA RHOC	1.63e-05	2	141	2	19642867
Pubmed	Involvement of β-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparum.	DEFB130B DEFB130A	1.63e-05	2	141	2	28181499
Pubmed	Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.	ERVK-6 ERVK-18	1.63e-05	2	141	2	11672541
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	GPC1 WASHC2C THSD7A DHX57 NEDD1 SLIT2 PRRC2C SLIT1 EIF5B NFAT5	2.58e-05	475	141	10	31040226
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	CCP110 SRR HUWE1 PARS2 RHOA RHOC LARP4B PRRC2C SEC23IP DDX23 EXOC2	3.92e-05	606	141	11	36538041
Pubmed	RhoA, RhoB and RhoC have different roles in cancer cell migration.	RHOA RHOC	4.88e-05	3	141	2	23488932
Pubmed	A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.	RHOA RHOC	4.88e-05	3	141	2	12939257
Pubmed	Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.	RHOA RHOC	4.88e-05	3	141	2	17018591
Pubmed	RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).	RHOA RHOC	4.88e-05	3	141	2	24096540
Pubmed	Structural and mechanistic insights into the interaction between Rho and mammalian Dia.	RHOA RHOC	4.88e-05	3	141	2	15864301
Pubmed	Cloning and expressions of three mammalian homologues of Drosophila slit suggest possible roles for Slit in the formation and maintenance of the nervous system.	SLIT2 SLIT1	4.88e-05	3	141	2	9813312
Pubmed	Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases.	RHOA RHOC	4.88e-05	3	141	2	29500478
Pubmed	Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.	KMT2D KMT2A	4.88e-05	3	141	2	26902498
Pubmed	RhoA, RhoB and RhoC differentially regulate endothelial barrier function.	RHOA RHOC	4.88e-05	3	141	2	28949796
Pubmed	Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.	KMT2D KMT2A	4.88e-05	3	141	2	23932714
Pubmed	Axonal growth regulation of fetal and embryonic stem cell-derived dopaminergic neurons by Netrin-1 and Slits.	SLIT2 SLIT1	4.88e-05	3	141	2	16840550
Pubmed	Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.	ERVK-6 ERVK-11	4.88e-05	3	141	2	9971820
Pubmed	Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer.	CASP1 CASP2	4.88e-05	3	141	2	8044845
Pubmed	Expression of candidate cell death genes in cell lines during apoptosis.	CASP1 CASP2	4.88e-05	3	141	2	7654317
Pubmed	A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.	RHOA RHOC	4.88e-05	3	141	2	21087931
Pubmed	RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication.	RHOA RHOC	4.88e-05	3	141	2	20697357
Pubmed	Syndecan-2 regulation of morphology in breast carcinoma cells is dependent on RhoGTPases.	RHOA RHOC	4.88e-05	3	141	2	24447566
Pubmed	The RhoA-binding protein, rhophilin-2, regulates actin cytoskeleton organization.	RHOA RHPN2	4.88e-05	3	141	2	12221077
Pubmed	Rho isoforms have distinct and specific functions in the process of epithelial to mesenchymal transition in renal proximal tubular cells.	RHOA RHOC	4.88e-05	3	141	2	19477269
Pubmed	RhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis.	RHOA RHOC	4.88e-05	3	141	2	21757538
Pubmed	Proteolytic processing of delta-like 1 by ADAM proteases.	ADAM9 ADAM12	4.88e-05	3	141	2	17107962
Pubmed	Sphingosine 1-phosphate-induced motility and endocytosis of dendritic cells is regulated by SWAP-70 through RhoA.	CASP1 RHOA	4.88e-05	3	141	2	21421853
Pubmed	Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion.	SLIT2 SLIT1	4.88e-05	3	141	2	24065825
Pubmed	RhoA and RhoC are involved in stromal cell-derived factor-1-induced cell migration by regulating F-actin redistribution and assembly.	RHOA RHOC	4.88e-05	3	141	2	28536953
Pubmed	A metalloprotease-disintegrin participating in myoblast fusion.	ADAM9 ADAM12	4.88e-05	3	141	2	7566181
Pubmed	Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain.	SLIT2 SLIT1	4.88e-05	3	141	2	16162649
Pubmed	Divergence of Rho residue 43 impacts GEF activity.	RHOA RHOC	4.88e-05	3	141	2	22673745
Pubmed	The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells.	RHOA RHOC	4.88e-05	3	141	2	26741994
Pubmed	Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.	RHOA RHOC	4.88e-05	3	141	2	19421144
Pubmed	Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.	ERVK-6 ERVK-18	4.88e-05	3	141	2	10516026
Pubmed	Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.	RHOA RHOC	4.88e-05	3	141	2	15642170
Pubmed	A molecular mechanism for the heparan sulfate dependence of slit-robo signaling.	SLIT2 SLIT1	4.88e-05	3	141	2	17062560
Pubmed	Conserved modularity and potential for alternate splicing in mouse and human Slit genes.	SLIT2 SLIT1	4.88e-05	3	141	2	12141424
Pubmed	Cell surface glypicans are low-affinity endostatin receptors.	GPC1 GPC4	4.88e-05	3	141	2	11336704
Pubmed	Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells.	RHOA RHOC	4.88e-05	3	141	2	27147504
Pubmed	SmgGDS is a guanine nucleotide exchange factor that specifically activates RhoA and RhoC.	RHOA RHOC	4.88e-05	3	141	2	21242305
Pubmed	MLL histone methylases regulate expression of HDLR-SR-B1 in presence of estrogen and control plasma cholesterol in vivo.	KMT2D KMT2A	4.88e-05	3	141	2	23192982
Pubmed	Expression and subcellular localization of Spred proteins in mouse and human tissues.	SPRED1 ATP2B4	4.88e-05	3	141	2	15580519
Pubmed	Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients.	RHOA RHOC	4.88e-05	3	141	2	31324164
Pubmed	The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization.	RHOA SPRED1	4.88e-05	3	141	2	15184877
Pubmed	Developmental clock and mechanism of de novo polarization of the mouse embryo.	TFAP2C RHOA	4.88e-05	3	141	2	33303584
Pubmed	The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton.	RHOA RHOC	4.88e-05	3	141	2	8816443
Pubmed	RhoA/C inhibits proliferation by inducing the synthesis of GPRC5A.	RHOA RHOC	4.88e-05	3	141	2	32719397
Pubmed	Modulation of Both Intrinsic and Extrinsic Factors Additively Promotes Rewiring of Corticospinal Circuits after Spinal Cord Injury.	RHOA RHOC	4.88e-05	3	141	2	34759029
Pubmed	New neurons follow the flow of cerebrospinal fluid in the adult brain.	SLIT2 SLIT1	4.88e-05	3	141	2	16410488
Pubmed	Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia.	KMT2D KMT2A	4.88e-05	3	141	2	30315824
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	CCP110 XRN2 ACACB SLIT2 KMT2D LRBA HERC1	5.02e-05	234	141	7	36243803
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-18 ERVK-25 ERVK-11	5.09e-05	18	141	3	18664271
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ACACB GEMIN2 LCORL HUWE1 CRKL KMT2D ZNF592 SEC23IP LRBA	5.56e-05	418	141	9	34709266
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CYLD JCAD XRN2 HIVEP2 NRCAM AKAP17A ADAM9 WHAMM HUWE1 SLF2 ZNF592 CIAO3 SEC23IP CCDC15 SPRED1 LRBA	6.94e-05	1285	141	16	35914814
Pubmed	Human transcription factor protein interaction networks.	CYLD ASXL1 XRN2 ATXN7L2 ACACB MBD6 RHOA LARP4B KMT2D ZSCAN21 NKX2-4 ZNF592 PRRC2C PIP4P1 CBX1 KMT2A HERC1	7.11e-05	1429	141	17	35140242
Pubmed	Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families.	ACACB ADAM9 CDKAL1 CRKL SEC23IP SPRED1 LRBA IL6ST	7.72e-05	339	141	8	37232246
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	XRN2 GCFC2 WASHC2C HUWE1 CTTNBP2NL KMT2D PTPRC ZNF592 EIF5B KMT2A UTP20 EXOC2	7.89e-05	774	141	12	15302935
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	XRN2 DHX57 HUWE1 TFAP2C LARP4B NKX2-4 GPC4 UTP20	9.44e-05	349	141	8	25665578
Pubmed	Parabrachial CGRP Neurons Establish and Sustain Aversive Taste Memories.	GRIN1 ARC	9.74e-05	4	141	2	30344042
Pubmed	Carm1 regulates Pax7 transcriptional activity through MLL1/2 recruitment during asymmetric satellite stem cell divisions.	KMT2D KMT2A	9.74e-05	4	141	2	22863532
Pubmed	KDM5A noncanonically binds antagonists MLL1/2 to mediate gene regulation and promotes epithelial to mesenchymal transition.	KMT2D KMT2A	9.74e-05	4	141	2	37722486
Pubmed	Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia.	ASXL1 PTPRC	9.74e-05	4	141	2	19861679
Pubmed	The Rho target PRK2 regulates apical junction formation in human bronchial epithelial cells.	RHOA RHOC	9.74e-05	4	141	2	20974804
Pubmed	RhoC in association with TET2/WDR5 regulates cancer stem cells by epigenetically modifying the expression of pluripotency genes.	RHOC KMT2A	9.74e-05	4	141	2	36469134
Pubmed	Contralateral migration of oculomotor neurons is regulated by Slit/Robo signaling.	SLIT2 SLIT1	9.74e-05	4	141	2	27770832
GeneFamily	Fibronectin type III domain containing	NRCAM ANOS1 PTPRC LRFN5 CNTN5 IL6ST	8.79e-05	160	82	6	555
GeneFamily	Glypicans	GPC1 GPC4	3.01e-04	6	82	2	572
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NRCAM MDGA2 LRFN5 CNTN5 MUSK	8.27e-04	161	82	5	593
GeneFamily	Caspases\|Caspase recruitment domain containing	CASP1 CASP2	1.53e-03	13	82	2	468
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFHR5 HP C1R	2.21e-03	57	82	3	1179
GeneFamily	Rho family GTPases	RHOA RHOC	3.66e-03	20	82	2	390
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	CYLD XRN2 HIVEP2 VPS13C CASP1 HUWE1 ATP8B2 RHOA CCNH CCDC88C TGFBR3 KMT2D CD5 PTPRC SLF2 SERINC1 TLN1 MYO1F KMT2A LRBA HERC1 NFAT5 ATP2B4 RBM38	5.30e-07	1492	134	24	M40023
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GPC1 THSD7A VPS13C GFRA1 PRRC2C TLN1 KMT2A C1R PLXNA2 IL6ST	5.57e-10	199	135	10	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XRN2 VPS13C PTPRC SLF2 PRRC2C TLN1 CBX1 DDX23 KMT2A	5.28e-09	184	135	9	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	VPS13C HUWE1 CRY1 PTPRC KMT2A LRBA HERC1 NFAT5 IL6ST	6.37e-09	188	135	9	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	THSD7A ACACB NRCAM SMOC2 BPIFA1 TGFBR3 SLIT2 ARC	9.56e-08	184	135	8	e33e2a887aafba7b6a31f00bb0dbe974b4359fd6
ToppCell	(2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)\|World / Stress and Cell class	GPC1 LARS2 RHOC TGFBR3 SLIT2 HP ERRFI1 GPC4	1.38e-07	193	135	8	f31398dad5321a7bcb27e208bd73630e9756e897
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	HUWE1 CCNH PTPRC LRBA HERC1 IL6ST TMEM63A	1.36e-06	181	135	7	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	CCP110 ICE2 CRY1 SUOX CIAO3 SGO2 TMEM63A	1.52e-06	184	135	7	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	VPS13C HUWE1 CDKAL1 KMT2D PTPRC LRBA NFAT5	1.58e-06	185	135	7	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD7A VPS13C SMOC2 GFRA1 SLF2 PRRC2C ERRFI1	1.95e-06	191	135	7	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CLSTN2 SMOC2 GFRA1 SLIT2 LRFN5 ADAMTS16 C1R	2.02e-06	192	135	7	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	VPS13C CCDC88C CD5 KMT2A LRBA HERC1 ATP2B4	2.24e-06	195	135	7	4b9663509cc5e3f409f6d0d37640cb301a827d98
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLSTN2 SMOC2 GFRA1 TGFBR3 ARC C1R IL6ST	2.24e-06	195	135	7	fc43cd295f2cc3f6e9442232e028944f011c82cc
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CYLD HIVEP2 ATP8B2 CD5 KMT2A IL6ST TMEM63A	2.24e-06	195	135	7	22191d361af136942508f1553ff41a626ed982ad
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LARS2 TGFBR3 SERINC1 PRRC2C ERRFI1 SPRED1 IL6ST	2.31e-06	196	135	7	66d76249bd2770cdddff2c1fe59a016e95da2124
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LARS2 TGFBR3 SERINC1 PRRC2C ERRFI1 SPRED1 IL6ST	2.31e-06	196	135	7	9bd4c146fc7555e32adfa393b3a07846eb826d25
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CYLD THSD7A PTPRC PRRC2C KMT2A LRBA HERC1	2.39e-06	197	135	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLSTN2 SMOC2 GFRA1 TGFBR3 ARC C1R IL6ST	2.39e-06	197	135	7	ab5d3ebc73bd7cfc64381d14b92878b370205186
ToppCell	healthy_donor-Lymphocytic-T_cell-CD4+_Naive_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	CYLD HIVEP2 NRCAM ATP8B2 CD5 IL6ST TMEM63A	2.39e-06	197	135	7	cf72160f03105876641fa6fdc7405e339eb084c7
ToppCell	healthy_donor-Lymphocytic-T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	CYLD HIVEP2 ATP8B2 CD5 KMT2A IL6ST TMEM63A	2.39e-06	197	135	7	63d0f06e150e7eb800ecb70e97b9d12a01c84e37
ToppCell	COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	CYLD HIVEP2 ATP8B2 CD5 KMT2A IL6ST TMEM63A	2.47e-06	198	135	7	58f208b76cb0adcecdf632d92f92833a06f9bf71
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CLSTN2 GFRA1 LRFN5 GPC4 ADAMTS16 C1R CXCL6	2.56e-06	199	135	7	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CLSTN2 GFRA1 LRFN5 GPC4 ADAMTS16 C1R CXCL6	2.56e-06	199	135	7	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CCNH CCDC88C TGFBR3 PTPRC PRRC2C KMT2A ATP2B4	2.64e-06	200	135	7	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	HIVEP2 CRY1 CCNH PTPRC HERC1 IL6ST	8.20e-06	156	135	6	1545169694f686d28648a68b552c2ae606599d66
ToppCell	droplet-Spleen-SPLEEN-30m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPC1 SMOC2 ADAM12 RHOC BAIAP3 CPNE7	1.13e-05	165	135	6	e24621c8d4dbafb407033d832fe9337f13feae34
ToppCell	droplet-Spleen-nan-21m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPC1 SMOC2 ADAM12 RHOC BAIAP3 CPNE7	1.21e-05	167	135	6	92ddabbe55315856d8ea6f8db1560b6d97636bac
ToppCell	facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 LARS2 CNTN5 ERRFI1 GPC4 HAAO	1.29e-05	169	135	6	ee27bcfe3f9a295ec5fb0a375d77d1050e5cbaad
ToppCell	facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 LARS2 CNTN5 ERRFI1 GPC4 HAAO	1.29e-05	169	135	6	922086f218135b734b7d370b871923e50141edce
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK9 EFHB CCDC88C CFAP54 SLIT1 BAIAP3	1.29e-05	169	135	6	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	droplet-Marrow-nan-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 ATXN7L2 ERRFI1 HAAO SPRED1 IL6ST	1.53e-05	174	135	6	55cc8300489d11322724159ec7d0e1d32a702e91
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MDGA2 GFRA1 CFAP54 LRFN5 GPC4 ADAMTS16	1.74e-05	178	135	6	544379f5a6145429762258d426b876bb36c112f5
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	THSD7A ADAM12 ATP8B2 MYO1F ADAMTS16 HHIPL1	1.79e-05	179	135	6	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	IPF-Epithelial-Mesothelial\|IPF / Disease state, Lineage and Cell class	SMOC2 MST1 SLIT2 HP C1R CXCL6	1.85e-05	180	135	6	1fa54bf4dba72866b2295639d991af639341bc08
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	TGFBR3 PTPRC TLN1 MYO1F ERRFI1 ATP2B4	2.03e-05	183	135	6	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	IPF-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	SMOC2 MST1 SLIT2 HP C1R CXCL6	2.03e-05	183	135	6	7df20e3172a1220ff427f30181f4f0c3b7fe2d42
ToppCell	P07-Epithelial-airway_epithelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TTLL9 PIH1D2 AK9 GFRA1 CFAP54 HP	2.09e-05	184	135	6	a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2
ToppCell	P07-Epithelial-airway_epithelial_cell-club_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TTLL9 PIH1D2 AK9 GFRA1 CFAP54 HP	2.09e-05	184	135	6	ab469b9e06212462cbe2e4db8775c6778db855e6
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D122\|Adult / Lineage, Cell type, age group and donor	CLSTN2 SMOC2 GFRA1 TGFBR3 SLIT2 LRFN5	2.09e-05	184	135	6	2b7e6f91e11c228f0521e099886867d9e998e78d
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A ADAM12 GFRA1 TGFBR3 SLIT2 CNTN5	2.09e-05	184	135	6	658f2e522055e88c92bc482a845c40f8f5f1a8e3
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	ADGRL1 ADAM12 TGFBR3 PTPRC MYO1F ATP2B4	2.09e-05	184	135	6	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	SMOC2 GFRA1 TGFBR3 SLIT2 LRFN5 C1R	2.16e-05	185	135	6	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Th1\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAM12 CD5 PTPRC MYO1F ATP2B4 CPNE7	2.16e-05	185	135	6	326c8b6ea0e9140616d7b867db1385b980dc3678
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CASP2 CCDC88C CD5 KMT2A LRBA CPNE7	2.22e-05	186	135	6	bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	JCAD HIVEP2 ADAM12 ARC KCNMB4 ATP2B4	2.22e-05	186	135	6	56c139e679d640ea901ead657a8e8887e0fca098
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	VPS13C HUWE1 CDKAL1 PTPRC LRBA NFAT5	2.22e-05	186	135	6	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HIVEP2 ATP8B2 CD5 PTPRC SERINC1 IL6ST	2.29e-05	187	135	6	e61c1755531469dd3850c9740474b5ad4e0499c1
ToppCell	Control-Endothelial_cells-Arterial_endothelial_cells\|Control / group, cell type (main and fine annotations)	JCAD THSD7A CTTNBP2NL ARC KCNMB4 PLXNA2	2.29e-05	187	135	6	81affaab3fe3e1daea45ada6445e906ddd33950e
ToppCell	(1)_T_CD4_naive\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	CYLD ATP8B2 CD5 PTPRC IL6ST TMEM63A	2.36e-05	188	135	6	b8f67ac2faadd5b848955e43ab5d6cf5e49b3681
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	SMOC2 GFRA1 TGFBR3 SLIT2 LRFN5 C1R	2.36e-05	188	135	6	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ADAM12 GFRA1 SLIT2 ERRFI1 GPC4 C1R	2.36e-05	188	135	6	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLSTN2 GFRA1 TGFBR3 SLIT2 ADAMTS16 C1R	2.43e-05	189	135	6	d531399749409d614adca13d181830c6e3287508
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	GFRA1 TGFBR3 SLIT2 LRFN5 ADAMTS16 C1R	2.51e-05	190	135	6	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	JCAD THSD7A CTTNBP2NL ARC KCNMB4 PLXNA2	2.58e-05	191	135	6	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	Adult-Immune-T_lymphocyte-D175\|Adult / Lineage, Cell type, age group and donor	HIVEP2 ADAM12 ATP8B2 CCDC88C CD5 PTPRC	2.58e-05	191	135	6	0b84fd1dc68146d9f72422b102744d2847f5ecb2
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	VPS13C HUWE1 CDKAL1 PTPRC LRBA NFAT5	2.58e-05	191	135	6	9454f642c3621370fa23640b631301346b300950
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GPC1 ALDH8A1 SMOC2 ANOS1 ADAMTS16 C1R	2.58e-05	191	135	6	44b1f62fdee03b157fe545f2ae6ff84f8929a8ac
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	SMOC2 TGFBR3 SLIT2 SCCPDH C1R MUSK	2.58e-05	191	135	6	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	CLSTN2 GFRA1 TGFBR3 SLIT2 LRFN5 MUSK	2.58e-05	191	135	6	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CCNH CCDC88C TGFBR3 CD5 ATP2B4 TMEM63A	2.58e-05	191	135	6	4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Th17_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ADAM12 RHOA CCNH MYO1F ATP2B4 CPNE7	2.66e-05	192	135	6	12f7ea575da5d650c740e6060f5dab0478e563dd
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CYLD HIVEP2 CD5 KMT2A IL6ST TMEM63A	2.66e-05	192	135	6	35557254738844c27ffcd00f3287fbcc0a4d0f3b
ToppCell	(0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells\|(0)_Normal/No_Treatment / Stress and Cell class	GPC1 TGFBR3 SLIT2 HP ERRFI1 GPC4	2.66e-05	192	135	6	7a2ad0bdae647b88e799e62767605f2f3c5a426f
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	CLSTN2 TGFBR3 SLIT2 LRFN5 C1R MUSK	2.66e-05	192	135	6	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CYLD ASXL1 HIVEP2 CRY1 NFAT5 IL6ST	2.66e-05	192	135	6	6bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	CRY1 CCNH PTPRC KMT2A HERC1 IL6ST	2.66e-05	192	135	6	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYLD HIVEP2 ATP8B2 CD5 IL6ST TMEM63A	2.66e-05	192	135	6	7ab626a516b07d899175ff12f1c8257688324e4b
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	SMOC2 GFRA1 TGFBR3 SLIT2 LRFN5 C1R	2.66e-05	192	135	6	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 SMOC2 TFAP2C SCCPDH GPC4 NFAT5	2.74e-05	193	135	6	0f2167eef8203a5659c8c72e4e77646003d64797
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYLD HIVEP2 ATP8B2 CD5 IL6ST TMEM63A	2.74e-05	193	135	6	194b49c152e3e3f599068ec88a7f0af6427b743a
ToppCell	LA\|World / Chamber and Cluster_Paper	CLSTN2 SMOC2 TGFBR3 SLIT2 HP C1R	2.74e-05	193	135	6	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CLSTN2 SMOC2 GFRA1 SLIT2 LRFN5 C1R	2.74e-05	193	135	6	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	THSD7A ADAM12 ATP8B2 SLIT2 ADAMTS16 HHIPL1	2.74e-05	193	135	6	194e7fa00a50cc4e026987b715323d125d79594e
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ASXL1 XRN2 CDKAL1 PRRC2C LRBA NFAT5	2.74e-05	193	135	6	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CLSTN2 SMOC2 GFRA1 TGFBR3 SLIT2 C1R	2.74e-05	193	135	6	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	CD8+_Memory_T_cell-CV-6\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	CYLD UPF3A RHOC TGFBR3 TLN1 ATP2B4	2.82e-05	194	135	6	35a347c3824757b9de8b7f49db46e73e7fb63a4f
ToppCell	BLOOD--(1)_T_cell-(1)_MAIT-like_CD8_T_cells\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CASP1 RHOC CCNH TGFBR3 PTPRC MYO1F	2.82e-05	194	135	6	830342a4df39c24c30fb4746ce762af697716148
ToppCell	normal_Pleural_Fluid-T/NK_cells-CD8_low_T\|T/NK_cells / Location, Cell class and cell subclass	CASP1 RHOC CD5 MYO1F ATP2B4 CPNE7	2.82e-05	194	135	6	cf2480cc40f3c9be837b3934547e2ce30bd4fcd3
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	CLSTN2 SMOC2 TGFBR3 SLIT2 C1R MUSK	2.82e-05	194	135	6	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	CV-Severe-6\|Severe / Virus stimulation, Condition and Cluster	RHOC TGFBR3 SERINC1 TLN1 KMT2A ATP2B4	2.82e-05	194	135	6	d33be6ed1de907aeea0c2dce09796556b8efdd4e
ToppCell	remission-CD4+_Tcm\|World / disease stage, cell group and cell class	CYLD ADAM12 ATP8B2 PTPRC CPNE7 TMEM63A	2.90e-05	195	135	6	365a06e2fb48ec5262a4e2580ba5a592e48127e0
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CLSTN2 GFRA1 CRY1 TGFBR3 SLIT2 C1R	2.90e-05	195	135	6	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CYLD HIVEP2 ATP8B2 CD5 KMT2A IL6ST	2.90e-05	195	135	6	4bdedd924564a260841a9153604026b57487c83d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLSTN2 ATP8B2 GFRA1 TGFBR3 SLIT2 C1R	2.90e-05	195	135	6	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	(3)_Chondrocytes-(30)_Chondro\|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis	NRCAM MDGA2 CLSTN2 SMOC2 GFRA1 GPC4	2.90e-05	195	135	6	f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMOC2 CTTNBP2NL GFM2 PRRC2C TLN1 LRBA	2.90e-05	195	135	6	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	ASK428-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	SMOC2 MST1 HP C1R SGO2 CXCL6	2.90e-05	195	135	6	c750602c765a51075ba6ede78e3ba80b62374481
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	ADGRL1 ADAM12 CCDC88C TGFBR3 PTPRC ATP2B4	2.90e-05	195	135	6	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ATP8B2 CCDC88C TGFBR3 CD5 PTPRC ATP2B4	2.98e-05	196	135	6	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	CYLD HUWE1 CCDC88C TLN1 EIF5B KMT2A	2.98e-05	196	135	6	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ADGRL1 ADAM12 CCDC88C TGFBR3 PTPRC ATP2B4	2.98e-05	196	135	6	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRL1 ADAM12 CCDC88C TGFBR3 PTPRC ATP2B4	2.98e-05	196	135	6	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADGRL1 ADAM12 CCDC88C TGFBR3 PTPRC ATP2B4	2.98e-05	196	135	6	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRL1 ADAM12 CCDC88C TGFBR3 PTPRC ATP2B4	2.98e-05	196	135	6	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LARS2 RHOA SERINC1 PRRC2C SPRED1 IL6ST	2.98e-05	196	135	6	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CCDC88C TGFBR3 CD5 PTPRC KMT2A ATP2B4	3.07e-05	197	135	6	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	Parenchymal-10x5prime-Stromal-Mesofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ALDH8A1 SMOC2 MST1 HP C1R CXCL6	3.07e-05	197	135	6	88a86286b9c3ea3b076d7464faec42d0392ee7f8
ToppCell	Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ALDH8A1 SMOC2 MST1 HP C1R CXCL6	3.07e-05	197	135	6	2773d2eb5f232a7e49da116efffcb6bf5eb90810
ToppCell	healthy_donor-Lymphocytic-T_cell-CD4+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	CYLD HIVEP2 ATP8B2 CD5 IL6ST TMEM63A	3.07e-05	197	135	6	c842d169dfce9af3ed7c01dc7e940c0bdd21388c
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GPC1 ADAM12 RHOC SLIT2 ERRFI1 SPRED1	3.07e-05	197	135	6	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	5'-Adult-Appendix-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLSTN2 SMOC2 GFRA1 TGFBR3 ARC C1R	3.07e-05	197	135	6	b11a5d909942a4299cbc0b27332b1a3f66f3bccd
Drug	PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A	GPC1 ADGRL1 UPF3A LARS2 ATP8B2 DUS2 TGFBR3 SCCPDH CIAO3 SEC23IP TMEM63A	2.64e-08	198	134	11	7076_UP
Drug	Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	CASP2 ADGRL1 UPF3A CCDC88C SLF2 CIAO3 NFAT5 IL6ST TMEM63A	2.60e-06	197	134	9	5811_DN
Drug	Azathymine, 6 [932-53-6]; Up 200; 31.4uM; HL60; HT_HG-U133A	GPC1 THSD7A GRIN1 CFHR5 HUWE1 RHOC CD5 BAIAP3 IL6ST	2.60e-06	197	134	9	2466_UP
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A	GCFC2 THSD7A DHX57 SRR CCDC88C ZNF592 CIAO3 EIF5B TMEM63A	2.71e-06	198	134	9	1184_DN
Drug	Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HT_HG-U133A	GPC1 CASP1 ADGRL1 ADAM12 TFAP2C DUS2 IL6ST TMEM63A	2.08e-05	195	134	8	6650_DN
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	CYLD CASP2 ADAM12 TFAP2C CDKAL1 LARP4B ZNF592 TMEM63A	2.16e-05	196	134	8	6708_DN
Drug	Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	GPC1 ADGRL1 DUS2 LARP4B GPC4 KMT2A IL6ST TMEM63A	2.24e-05	197	134	8	1693_DN
Drug	Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	CYLD JCAD ACACB CASP2 ADAM12 PRRC2C NFAT5 TMEM63A	2.24e-05	197	134	8	2103_UP
Drug	Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; MCF7; HT_HG-U133A	HIVEP2 CASP2 XK UPF3A LRP5 KCNMB4 NFAT5 TMEM63A	2.24e-05	197	134	8	3443_DN
Drug	Naproxen [22204-53-1]; Down 200; 17.4uM; HL60; HT_HG-U133A	ASXL1 GCFC2 HIVEP2 CRY1 TGFBR3 CIAO3 EIF5B CPNE7	2.32e-05	198	134	8	1869_DN
Drug	Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A	HIVEP2 DHX57 DUS2 LARP4B SEC23IP LRP5 KCNMB4 NFAT5	2.32e-05	198	134	8	6208_DN
Drug	oxamic acid sodium salt; Down 200; 10000uM; MCF7; HG-U133A	ASXL1 CASP2 ADAM12 DUS2 SEC23IP GPC4 KMT2A NFAT5	2.41e-05	199	134	8	439_DN
Drug	Chlorhexidine [55-56-1]; Down 200; 8uM; MCF7; HT_HG-U133A	CASP1 CASP2 ATP8B2 CDKAL1 SEC23IP KCNMB4 IL6ST TMEM63A	2.50e-05	200	134	8	5403_DN
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; PC3; HT_HG-U133A	CYLD JCAD ACACB CASP1 ADGRL1 SRR DUS2 CCN3	2.50e-05	200	134	8	5828_DN
Drug	Roussin's black salt	ESCO2 CIAO3	3.44e-05	2	134	2	CID003081476
Drug	Chlorpyrifos	ATXN7L2 NRCAM ALDH8A1 CASP1 GRIN1 HUWE1 EFHB ATP8B2 DUS2 SLIT2 HP SLIT1 ERRFI1 ARC KMT2A NFAT5 ATP2B4	4.99e-05	960	134	17	ctd:D004390
Drug	12-mo	ADGRL1 XK PTPRC LRP5	6.52e-05	37	134	4	CID000001420
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	CYLD CASP1 HUWE1 LARP4B CXCL6 CCN3 TMEM63A	1.07e-04	183	134	7	6166_UP
Drug	Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A	CASP2 CDKAL1 CRKL DUS2 KMT2A CCN3 TMEM63A	1.19e-04	186	134	7	3819_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A	GPC1 ADGRL1 HUWE1 TLN1 BAIAP3 CPNE7 TMEM63A	1.36e-04	190	134	7	4274_UP
Drug	Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	CASP2 TFAP2C CRKL LARP4B KMT2A NFAT5 IL6ST	1.36e-04	190	134	7	2869_DN
Drug	Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A	CYLD CASP1 CASP2 KMT2A IL6ST CPNE7 TMEM63A	1.36e-04	190	134	7	4421_DN
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ACACB CASP2 CLSTN2 LARP4B NFAT5 IL6ST TMEM63A	1.40e-04	191	134	7	3605_DN
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA	GPC1 CYLD XK LARS2 CCDC88C CIAO3 ATP2B4	1.40e-04	191	134	7	991_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	CASP2 LARP4B PRRC2C SEC23IP NFAT5 IL6ST TMEM63A	1.45e-04	192	134	7	3252_DN
Drug	Tolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	GPC1 CYLD CASP1 ARC BAIAP3 PLXNA2 IL6ST	1.49e-04	193	134	7	3347_UP
Drug	Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	CASP2 ADGRL1 UPF3A CEMP1 TGFBR3 NFAT5 BAIAP3	1.49e-04	193	134	7	3250_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	CYLD CASP2 ADGRL1 HUWE1 HAAO CPNE7 TMEM63A	1.49e-04	193	134	7	6981_UP
Drug	Dadi	SRR CD5 PTPRC	1.52e-04	18	134	3	CID000007069
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A	GPC1 CYLD CASP1 CASP2 CDKAL1 NFAT5 TMEM63A	1.54e-04	194	134	7	4141_DN
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	HIVEP2 ACACB CASP1 UPF3A CDKAL1 DUS2 ZNF592	1.54e-04	194	134	7	1814_DN
Drug	Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A	CASP2 UPF3A CDKAL1 CRKL MYO1F KCNMB4 TMEM63A	1.54e-04	194	134	7	5047_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	GCFC2 SRR TFAP2C DUS2 LARP4B SLF2 CCDC15	1.59e-04	195	134	7	6966_DN
Drug	prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	CYLD NRCAM CASP2 DHX57 CLSTN2 ADAM12 GPC4	1.59e-04	195	134	7	6552_DN
Drug	Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; PC3; HT_HG-U133A	ACACB CASP1 ATP8B2 TFAP2C MYO1F RBM38 CPNE7	1.59e-04	195	134	7	6661_DN
Drug	Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; HL60; HT_HG-U133A	HIVEP2 ACACB ATP8B2 KMT2A LRP5 EXOC2 TMEM63A	1.64e-04	196	134	7	1849_UP
Drug	Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; PC3; HT_HG-U133A	TFAP2C CDKAL1 CRKL LARP4B KMT2A NFAT5 BAIAP3	1.64e-04	196	134	7	6760_DN
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A	ACACB ADGRL1 CDKAL1 KMT2A KCNMB4 BAIAP3 CPNE7	1.64e-04	196	134	7	2086_UP
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	CASP2 UPF3A ATP8B2 LARP4B NFAT5 IL6ST TMEM63A	1.64e-04	196	134	7	3268_DN
Drug	Prenylamine lactate [69-43-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A	CASP1 CASP2 ATP8B2 CCDC88C DUS2 KCNMB4 TMEM63A	1.64e-04	196	134	7	5489_DN
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	ADGRL1 HUWE1 CDKAL1 TRIM45 HAAO BAIAP3 TMEM63A	1.64e-04	196	134	7	3783_DN
Drug	Urosiol [128-13-2]; Up 200; 10.2uM; HL60; HT_HG-U133A	THSD7A NRCAM SRR CIAO3 LRP5 ATP2B4 CCN3	1.70e-04	197	134	7	3105_UP
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A	HIVEP2 CASP1 ADGRL1 CDKAL1 ARC KCNMB4 BAIAP3	1.70e-04	197	134	7	3692_DN
Drug	Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	UPF3A ZNF592 CIAO3 TLN1 SEC23IP IL6ST TMEM63A	1.70e-04	197	134	7	1680_DN
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A	ADGRL1 MYO1F CCDC15 KMT2A LRP5 IL6ST TMEM63A	1.70e-04	197	134	7	1695_UP
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A	CYLD ACACB CASP1 ADGRL1 NFAT5 CPNE7 TMEM63A	1.75e-04	198	134	7	3621_DN
Drug	6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A	CYLD ACACB CASP2 ATP8B2 CRKL MYO1F TMEM63A	1.75e-04	198	134	7	6073_DN
Drug	HA-1077 dihydrochloride; Up 200; 10uM; MCF7; HG-U133A	CASP1 CASP2 ADGRL1 CD5 KMT2A IL6ST CPNE7	1.75e-04	198	134	7	343_UP
Drug	ICI 182,780; Up 200; 0.01uM; HL60; HT_HG-U133A	CYLD THSD7A ACACB CLSTN2 SLIT2 KMT2A TMEM63A	1.75e-04	198	134	7	6197_UP
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A	CYLD CDKAL1 ARC KMT2A BAIAP3 CPNE7 TMEM63A	1.75e-04	198	134	7	7282_UP
Drug	Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; MCF7; HT_HG-U133A	CASP1 CASP2 XK CRKL BAIAP3 IL6ST TMEM63A	1.75e-04	198	134	7	7224_UP
Drug	Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A	CYLD CLSTN2 HUWE1 CDKAL1 BAIAP3 PLXNA2 TMEM63A	1.75e-04	198	134	7	3583_UP
Drug	(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; HL60; HT_HG-U133A	GPC1 ACACB CLSTN2 HUWE1 SLIT2 HAAO BAIAP3	1.75e-04	198	134	7	3067_UP
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A	CCP110 CASP1 CASP2 DHX57 LRBA NFAT5 TMEM63A	1.75e-04	198	134	7	2362_DN
Drug	0179445-0000 [211246-22-9]; Up 200; 1uM; PC3; HT_HG-U133A	GRIN1 CEMP1 LARP4B KMT2A BAIAP3 ATP2B4 IL6ST	1.75e-04	198	134	7	4292_UP
Drug	Felbinac [5728-52-9]; Up 200; 18.8uM; HL60; HT_HG-U133A	GPC1 CFHR5 ADAM12 CEMP1 KMT2D ARC BAIAP3	1.81e-04	199	134	7	3061_UP
Drug	Rifampicin [13292-46-1]; Down 200; 4.8uM; HL60; HT_HG-U133A	GCFC2 HIVEP2 TRIM45 DUS2 HAAO CPNE7 TMEM63A	1.81e-04	199	134	7	2487_DN
Drug	Gelsemine [509-15-9]; Up 200; 12.4uM; HL60; HT_HG-U133A	ACACB ADGRL1 CDKAL1 CRKL CIAO3 CXCL6 CPNE7	1.81e-04	199	134	7	2162_UP
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HG-U133A	VPS13C CASP2 LARP4B SEC23IP KMT2A HERC1 CCN3	1.81e-04	199	134	7	1960_DN
Drug	Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A	CYLD CASP1 CDKAL1 TLN1 KMT2A CXCL6 BAIAP3	1.81e-04	199	134	7	2320_UP
Drug	Acetohexamide [968-81-0]; Down 200; 12.4uM; PC3; HT_HG-U133A	CYLD CCP110 HIVEP2 GEMIN2 SRR UPF3A EIF5B	1.86e-04	200	134	7	1829_DN
Drug	Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A	CYLD CASP2 HUWE1 TGFBR3 CNTN5 BAIAP3 TMEM63A	1.86e-04	200	134	7	2278_UP
Drug	rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	CLSTN2 LARS2 ATP8B2 CCDC88C SLIT2 SEC23IP NFAT5	1.86e-04	200	134	7	5230_DN
Disease	Malignant neoplasm of breast	GPC1 XIRP1 ABCA4 NRCAM CFHR5 ADAM12 PKDREJ MST1 CCNH TRMT10A KMT2D PTPRC HP MAP7D2 UTP20 LRBA	2.81e-05	1074	133	16	C0006142
Disease	status epilepticus (biomarker_via_orthology)	XRN2 ADAM9 CASP2 GRIN1 IL6ST	9.22e-05	100	133	5	DOID:1824 (biomarker_via_orthology)
Disease	insular cortex volume measurement	THSD7A VPS13C SLIT2	1.48e-04	23	133	3	EFO_0010309
Disease	Familial Exudative Vitreoretinopathy	ABCA4 LRP5	2.00e-04	5	133	2	C0339539
Disease	Antiglaucoma preparations and miotics use measurement	THSD7A KMT2A EXOC2	2.16e-04	26	133	3	EFO_0009944
Disease	Gonadal dysgenesis XX type deafness	LARS2 SGO2	4.17e-04	7	133	2	C0685838
Disease	tumor necrosis factor ligand superfamily member 6, soluble form measurement	RHOA MST1	4.17e-04	7	133	2	EFO_0020797
Disease	ulcerative colitis (implicated_via_orthology)	RHOA RHOC	4.17e-04	7	133	2	DOID:8577 (implicated_via_orthology)
Disease	r-spondin-3 measurement	MST1 C1R	4.17e-04	7	133	2	EFO_0021878
Disease	phosphatidylcholine 38:2 measurement	CLSTN2 SCGB1D2 MUSK	5.27e-04	35	133	3	EFO_0010384
Disease	peroxisomal biogenesis disorder (implicated_via_orthology)	RHOA RHOC	5.55e-04	8	133	2	DOID:0080377 (implicated_via_orthology)
Disease	myelofibrosis (is_implicated_in)	ASXL1 KMT2A	5.55e-04	8	133	2	DOID:4971 (is_implicated_in)
Disease	body height at birth	HIVEP2 LCORL CDKAL1	7.83e-04	40	133	3	EFO_0006784
Disease	obsolete_9,10-dihome measurement	LCORL ICE2	8.86e-04	10	133	2	EFO_0021572
Disease	cholesteryl ester 20:5 measurement	JCAD CDKAL1 MUSK	1.04e-03	44	133	3	EFO_0010349
Disease	Vitiligo	SMOC2 PTPRC SUOX MUSK	1.15e-03	101	133	4	EFO_0004208
Disease	bipolar disorder	HIVEP2 THSD7A HUWE1 CDKAL1 KMT2D SLIT1 ATP2B4 MUSK CPNE7	1.25e-03	577	133	9	MONDO_0004985
Disease	outer ear morphology trait	HIVEP2 LRBA	1.29e-03	12	133	2	EFO_0007664
Disease	FEV/FEC ratio	JCAD ASXL1 HIVEP2 VPS13C ADAM12 CTTNBP2NL TFAP2C TGFBR3 SUOX CNTN5 MYO1F HHIPL1 EXOC2 HERC1	1.33e-03	1228	133	14	EFO_0004713
Disease	gallstones	LRBA NFAT5 MUSK CCN3	1.47e-03	108	133	4	EFO_0004210
Disease	colon carcinoma (is_marker_for)	CRKL KMT2D	1.52e-03	13	133	2	DOID:1520 (is_marker_for)
Disease	Birth Weight	LCORL CDKAL1	1.77e-03	14	133	2	C0005612
Disease	Cocaine-Related Disorders	ICE2 GRIN1 RHOA ARC	1.97e-03	117	133	4	C0236736
Disease	femoral neck bone mineral density	SMOC2 CDKAL1 RHPN2 CNTN5 LRP5	1.99e-03	196	133	5	EFO_0007785
Disease	platelet component distribution width	JCAD HIVEP2 SMOC2 CRKL PTPRC PRRC2C CNTN5 TLN1 HERC1 MUSK	2.28e-03	755	133	10	EFO_0007984
Disease	T-Cell Lymphoma	RHOA KMT2D	2.32e-03	16	133	2	C0079772
Disease	Cocaine Abuse	ICE2 GRIN1 RHOA ARC	2.66e-03	127	133	4	C0009171
Disease	Allergic Reaction	CASP1 HP IL6ST	2.92e-03	63	133	3	C1527304
Disease	Hypersensitivity	CASP1 HP IL6ST	3.05e-03	64	133	3	C0020517
Disease	forced expiratory volume	JCAD THSD7A LCORL WHAMM AK9 LARS2 SUOX LRP5 NFAT5 CCN3	3.12e-03	789	133	10	EFO_0004314
Disease	level of Sphingomyelin (d38:2) in blood serum	MYO1F MUSK	3.28e-03	19	133	2	OBA_2045179
Disease	schizophrenia (implicated_via_orthology)	HIVEP2 SRR GRIN1	3.62e-03	68	133	3	DOID:5419 (implicated_via_orthology)
Disease	polymyositis	THSD7A LRP5	3.63e-03	20	133	2	EFO_0003063
Disease	Cocaine Dependence	ICE2 GRIN1 RHOA ARC	3.67e-03	139	133	4	C0600427
Disease	amino acid measurement	GCFC2 ACACB ADAM12 SLIT2 CNTN5 SLIT1 LRBA CXCL6 PLXNA2	3.70e-03	678	133	9	EFO_0005134
Disease	neutrophil percentage of granulocytes	LARP4B PTPRC SUOX EXOC2 CXCL6	3.81e-03	228	133	5	EFO_0007994
Disease	bipolar I disorder	THSD7A ZNF592 ATP2B4 MUSK	3.87e-03	141	133	4	EFO_0009963
Disease	level of Phosphatidylcholine (16:0_20:4) in blood serum	CD5 MUSK	4.00e-03	21	133	2	OBA_2045076
Disease	chronic kidney disease	ABCA4 THSD7A ZAR1L LARP4B NFAT5	4.32e-03	235	133	5	EFO_0003884
Disease	progranulin measurement	ADGRL1 LRFN5	4.39e-03	22	133	2	EFO_0004625

Protein segments in the cluster

Peptide	Gene	Start	Entry
KKVECSPVQQAVPAQ	nan	176	Q6ZRG5
EKNDGEKQPVCTNPL	CTTNBP2NL	66	Q9P2B4
CKLLDKAGVPPGVVN	ALDH8A1	191	Q9H2A2
RIQKFKGPDITQQPC	CFAP54	1796	Q96N23
PNRVLQSVLKQGCPK	C9orf50	401	Q5SZB4
RCKAVANGKVLPNDP	CCNH	31	P51946
TKNPLNLPCQKELVG	TFAP2C	201	Q92754
VPGVCVKNLVKIFEP	ABCA4	926	P78363
VKNLVKIFEPCGRPA	ABCA4	931	P78363
VKENRGSFQPPVCNK	HAAO	11	P46952
GGPLPAKCIQVTEVK	BAIAP3	251	O94812
KVFVCPGTLQKVLEP	ADGRL1	136	O94910
QVAKPNVILQIGKCR	ARC	21	Q7LC44
KKVFVTCQDPNPAGL	CD5	361	P06127
LPAKPALRQAQGTCK	ADAM12	836	O43184
DTLVQVDVKPVCKPG	CLSTN2	246	Q9H4D0
KNEQKGEKIPRCLPV	C1R	436	P00736
NGKQVCLDPEAPFLK	CXCL6	86	P80162
PEVPDAIAKCKQAGI	ATP2B4	676	P23634
PEKTQKDNLCQPGGL	ATXN7L2	161	Q5T6C5
IEATQAPGAPQKNCK	ASXL1	1191	Q8IXJ9
AQAICLADQPKPVKE	ADAMTS16	486	Q8TE57
GEVICEPPNNKLDKF	ATP8B2	216	P98198
DQEVVIECKPQGSPK	CNTN5	496	O94779
ACKDPNPIIDGRKAN	RBM38	91	Q9H0Z9
LCAKKGLLFVPPNID	LRFN5	36	Q96NI6
ENPKLPELLCKNGVA	ACACB	356	O00763
ILLVKQGDCPAPEKA	ANOS1	126	P23352
KCGLECPLNVPKVFN	MBD6	61	Q96DN6
AVPVLVKDGKPCQNG	NKX2-4	276	Q9H2Z4
EAVCGKPKNPANPVQ	HP	146	P00738
CKPVPLLELAEGQKQ	NEDD1	66	Q8NHV4
KKEDPKVGVQPAVCV	MAP7D2	561	Q96T17
AQCPDVVVAQIDPKK	GEMIN2	61	O14893
RENIVIQCEAKGKPP	NRCAM	61	Q92823
PGKCQIQPAQVKIRS	HHIPL1	581	Q96JK4
TAKVIQGCGNPKVNP	GPC1	336	P35052
VQVSQKVFQGCGPPK	GPC4	331	O75487
VVKGEPTGPCNSKQL	JCAD	801	Q9P266
GIPAECQSGQKTVKP	KIAA1109	621	Q2LD37
NILPKQNKIECSGPV	LCORL	456	Q8N3X6
PKLIQGPLQGKVVVC	HERC1	501	Q15751
LKAVNVAKVVGTNPC	LRP5	591	O75197
LQPQKEQKPNTVGCG	LARP4B	666	Q92615
CKQESPQKLGAPEAL	CCDC88C	1821	Q9P219
LLGKDVQCTKAPVPI	PLXNA2	386	O75051
LECKPGEASVFQQPK	EXOC2	636	Q96KP1
IKLCGNDPDKIVVPL	HERVK_113	391	P63132
PIVFADPVKKACGVA	LACC1	286	Q8IV20
GPENCLKPKLIQASR	LRBA	2736	P50851
GPVFAKAIQKRVPCA	CRKL	236	P46109
VKTGQRTLINPKPCG	TMEM63A	291	O94886
PIIIFVNQKKGCDVL	DDX23	666	Q9BUQ8
PCLQAAKEQKEVQTP	HUWE1	1566	Q7Z6Z7
ILCTQPAGVPEILKK	NFAT5	436	O94916
IKLCGNDPDKIVVPL	ERVK-7	391	P63135
IKLCGNDPDKIVVPL	ERVK-6	391	Q9BXR3
IELQCQVTGKPKPII	MDGA2	461	Q7Z553
IKLCGNDPDKIVVPL	ERVK-18	391	Q9QC07
KTGVIPGQKQCIALK	DEFB130B	21	P0DP73
QPLPKGCAAVKAEVG	CEMP1	51	Q6PRD7
VCIQVIPVAGSKPVK	ICE2	306	Q659A1
PEKPKNLSCIVNEGK	IL6ST	126	P40189
LNKVLPELVQGNVCP	BPIFA1	211	Q9NP55
KPKVIIIQACRGDSP	CASP1	276	P29466
AEFQCSPGQIVKKPV	CCN3	311	P48745
VLPPCANLQAQKLKS	GFRA1	391	P56159
LLNATPGPDVVKKCN	GCFC2	686	P16383
PGPDVVKKCNQVAAC	GCFC2	691	P16383
KKIVLAGCVPQAQPR	CDKAL1	131	Q5VV42
LNGPPEKVANIICTQ	DHX57	586	Q6P158
PAALAKCVLAEVPKQ	CPNE7	591	Q9UBL6
PEGIQKVAKCLIGVN	CRY1	451	Q16526
QAPPGKALVENLCMK	DDX11L8	826	A8MPP1
LVPAKEANVKCPQVV	CBX1	146	P83916
NKGGNCLLNIPKPDE	ADAM9	396	Q13443
NNPINACELSPKGKE	CCP110	391	O43303
FIINGPKKIQCVDGE	CFHR5	241	Q9BXR6
NELGFQQVVPKCPNK	ESCO2	461	Q56NI9
VIIKGRKPDCVNPTE	EFHB	641	Q8N7U6
IPPCKRENQKNLESV	KCNMB4	116	Q86W47
QKECGQPAGQVAVLP	KMT2A	3601	Q03164
KTGVIPGQKQCIALK	DEFB130A	21	P0DP74
QELAQPGDLCKKPFV	DUS2	466	Q9NX74
ILDPPDQVQFEKCGK	MST1	456	P26927
KGLQIDVGCPVKVQL	CYLD	121	Q9NQC7
KPPVAKVKCGLDLNQ	CEP295	1831	Q9C0D2
VCNEATPIKNAPPGK	PIP4P1	106	Q86T03
DNKDGPVCLQVKPCT	CASP2	166	P42575
FCPNVPIILVGNKKD	RHOC	106	P08134
QACLIPPKKGSKEQA	PARS2	371	Q7L3T8
NLNLKPDVIINIKCP	AK9	136	Q5TCS8
CPVVLKENFILQPGN	AK9	936	Q5TCS8
KQKPGHPECDILTNV	UTP20	1221	O75691
FCPNVPIILVGNKKD	RHOA	106	P61586
PGVNDKIRFCPQEKA	TRIM45	366	Q9H8W5
PVLCGSALKNKGIQP	GFM2	326	Q969S9
GAPAQSCRPALQIKK	SAXO1	316	Q8IYX7
RVNVGQVGPKKCPES	THSD7A	741	Q9UPZ6
NNKACGKIPVPQQVA	LARS2	846	Q15031
PNIKICTQVKGPEAG	SCCPDH	356	Q8NBX0
KQESCAPGAVVKARP	UPF3A	311	Q9H1J1
PQIGECKINPAKGIA	PKDREJ	561	Q9NTG1
AKKGQEVCVKIEPIP	EIF5B	1151	O60841
VVEKRIACGPPQAKL	PRRC2C	216	Q9Y520
PACQNDSKIGKKPRL	SGO2	796	Q562F6
VPLSEAGNVKSPKCQ	WHAMM	596	Q8TF30
APPEAVAAKLGVKRC	SCGB1D2	51	O95969
QKDLNLSKCPGPLAV	SEC23IP	596	Q9Y6Y8
LVPLNAKNCALPVSK	SLF2	486	Q8IX21
VPQTAPDCKKLAIQA	SRR	106	Q9GZT4
LCLPSVGAARPQVKK	RHPN2	656	Q8IUC4
VPCILPIIENGKKVS	ERRFI1	376	Q9UJM3
NKIPGFCENEKGVVP	SERINC1	66	Q9NRX5
QPKGIPACEQNVSRK	AKAP17A	556	Q02040
DQGVLPKDQNILPIC	CCDC15	566	Q0P6D6
DFIGPSQECIKPVKV	CIAO3	16	Q9H6Q4
QKCKELQGFIPPLTD	CIART	121	Q8N365
IKLCGNDPDKIVVPL	ERVK-25	391	P63136
QQLKEGKQLCAAPEP	PIH1D2	36	Q8WWB5
QSHPQPVKCEGVKVD	ZNF513	6	Q8N8E2
EKGPLSPKVLFNQLC	USP45	266	Q70EL2
CVNLENEKGTKPPLQ	ZSCAN21	241	Q9Y5A6
EAKQPKNDNVVIPEC	SMOC2	226	Q9H3U7
AGPQPLLVQSCKAVA	TLN1	946	Q9Y490
ENVRGKCQDAPDPIK	SPRED1	346	Q7Z699
KTQVGVFKCPECPLL	ZNF592	886	Q92610
PKECNGVKIPVDASK	XRN2	26	Q9H0D6
IKLCGNDPDKIVVPL	ERVK-8	391	P63133
IKLCGNDPDKIVVPL	ERVK-11	391	Q9UQG0
IIQAPQKEVGKGCDP	WASHC2C	816	Q9Y4E1
VKNAVGVPIKVKPNC	VPS13C	2426	Q709C8
VLAILNKVAPQACPA	SLIT2	16	O94813
PSKKFTCQGPVDVNI	SLIT2	901	O94813
PGTTAIRCPKKLQNQ	TTLL9	11	Q3SXZ7
ILPQRKGAVPTDKAC	TRMT10A	271	Q8TBZ6
PVPAGQKELNIVCKA	SUOX	496	P51687
QKPQLVRQGCASEPK	HIVEP2	1491	P31629
KFECQGPPTLAVQAK	SLIT1	911	O75093
KQDANCVNPLGAPEK	PTPRC	1256	P08575
KKDITQCSVQPEPAP	XIRP1	1721	Q702N8
QQKPCEPIGKEDLQS	XK	401	P51811
KVGEDQVFPPKCNIG	TGFBR3	186	Q03167
PRLCKPNTKEVGVQV	ZAR1L	81	A6NP61
PLQCEAKPLGKAGVQ	KMT2D	411	O14686
NKVVCDLIENKLSPP	MYO1F	441	O00160
PNIVKLLGVCAVGKP	MUSK	636	O15146
VNGDPVKKVICTGPN	GRIN1	426	Q05586